NOVACELL+

Serial Number 99203389
686

Registration Progress

Application Filed
May 27, 2025
Under Examination
Approved for Publication
Nov 25, 2025
Published for Opposition
Nov 25, 2025
Registered

Trademark Image

NOVACELL+

Basic Information

Serial Number
99203389
Filing Date
May 27, 2025
Published for Opposition
November 25, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Nov 25, 2025
Application
Pending
Classes
005

Rights Holder

Bioxcellerator LLC

16
Address
4900 N. Scottsdale Rd., Suite 3700
Scottsdale, AZ 85251

Ownership History

Bioxcellerator LLC

Original Applicant
16
Scottsdale, AZ

Bioxcellerator LLC

Owner at Publication
16
Scottsdale, AZ

Legal Representation

Attorney
Perry Gattegno

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Nov 25, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 25, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 19, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 28, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 27, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 27, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 27, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 14, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 14, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 14, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 14, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 2, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 27, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 27, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biologics in the nature of pharmaceutical preparations for the treatment of chronic pain, inflammation, autoimmune diseases, and conditions benefiting from regenerative medicine being orthopedic and skin diseases and disorders, all for the purpose of accelerating healing and improvement of personal health and wellness; Pharmaceutical preparations for the treatment and prevention of chronic pain, inflammation, autoimmune diseases, and conditions benefiting from regenerative medicine in the nature of orthopedic and skin diseases and disorders, all for the purpose of accelerating healing and improvement of personal health and wellness; Pharmaceutical preparations for combined exosome and stem cell treatments for medical purposes; Pharmaceutical preparations for treating chronic conditions in the nature of orthopedic and skin diseases and disorders and autoimmune diseases using exosomes and stem cells for medical purposes, all for use in accelerating healing and improvement of personal health and wellness; Biologics in the nature of cells for the treatment of chronic conditions being orthopedic and skin diseases and disorders and autoimmune diseases using exosomes, extracellular vesicles, and stem cells for medical purposes; Biological preparations for the treatment of chronic conditions in the nature of orthopedic and skin diseases and disorders and autoimmune diseases using exosomes, extracellular vesicles, and stem cells for medical purposes, all for use in accelerating healing and improvement of personal health and wellness

Additional Information

Pseudo Mark
NOVACELL PLUS

Classification

International Classes
005